0000000000783887

AUTHOR

Rosaria Alba Cifarelli

showing 1 related works from this author

Epidoxorubicin and double biochemical 5-fluorouracil modulation with folinic acid and human lymphoblastoid interferon in advanced gastric carcinoma: …

1996

In our previous randomized trial of advanced gastric cancer patients, the addition of epirubicin (EPI) to 5-fluorouracil (FU) with folinic acid (FA) resulted in an improved response rate and survival in the responder patients. Preclinical studies also showed an enhancement of FU and anthracyclines with interferon. To evaluate the possibility of human lymphoblastoid interferon (IFN) to enhance the therapeutic activity of the FA-FU + EPI combination regimen, 39 advanced gastric cancer patients received: FU at 375 mg/m2 i.v. immediately after FA (l-isomer form) at 100 mg/m2 i.v. for 5 consecutive days; EPI at 60 mg/m2 i.v. on day 1, and IFN 3 MU s.c. for 7 consecutive days, starting 2 days bef…

OncologyAdultMaleCancer Researchmedicine.medical_specialtymedicine.medical_treatmentLeucovorinPhases of clinical researchFolinic acidStomach NeoplasmsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineCarcinomaHumansAgedEpirubicinNeoplasm StagingChemotherapybusiness.industryPatient SelectionInterferon-alphaGeneral MedicineMiddle Agedmedicine.diseaseCombined Modality TherapySurvival RateRegimenOncologyFluorouracilToxicityFemaleFluorouracilbusinessmedicine.drugEpirubicinOncology
researchProduct